Impact of a patient-centered tool to reduce misconceptions about coronary artery disease and its treatment: The CAD roadmap

PEC innovation Pub Date : 2024-06-06 DOI:10.1016/j.pecinn.2024.100303

Laura D. Scherer , Grace A. Lin , Vinay Kini

{"title":"Impact of a patient-centered tool to reduce misconceptions about coronary artery disease and its treatment: The CAD roadmap","authors":"Laura D. Scherer , Grace A. Lin , Vinay Kini","doi":"10.1016/j.pecinn.2024.100303","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Health misinformation is common and can lead to harmful behaviors such as medication non-adherence. We assessed the impact of a novel patient educational tool focused on overcoming misconceptions among patients with coronary artery disease (CAD).</p></div><div><h3>Methods</h3><p>We developed the CAD Roadmap, an educational tool aimed at explaining the disease trajectory and overcoming common disease misconceptions (such as that statin medications are not beneficial). We designed a pilot survey to assess patients' 1) CAD-related knowledge, 2) medication-taking behavior, and 3) acceptability of the Roadmap. Survey participants were recruited online. CAD knowledge scores were compared with repeated measures <em>t</em>-tests.</p></div><div><h3>Results</h3><p>Among 114 patients with CAD (mean age 67 years, 63% male), average CAD-related knowledge was 79.0% pre-test and 89.7% after review of the CAD Roadmap (<em>p</em> < .001). After review of the Roadmap, 24% indicated they planned to take their medications more regularly, 93% agreed it was helpful in understanding medication benefits, and 77% felt more empowered to participate in medical decisions.</p></div><div><h3>Conclusion</h3><p>The CAD Roadmap was evaluated positively, improved disease-related knowledge, and has the potential to improve adherence to treatments.</p></div><div><h3>Innovation</h3><p>Unlike many other interventions, the CAD Roadmap is specifically designed to overcome common misconceptions to improve health behaviors.</p></div>","PeriodicalId":74407,"journal":{"name":"PEC innovation","volume":"4 ","pages":"Article 100303"},"PeriodicalIF":0.0000,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772628224000517/pdfft?md5=c68b528fcf2a7658d890d3963ef4efc8&pid=1-s2.0-S2772628224000517-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PEC innovation","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772628224000517","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective

Health misinformation is common and can lead to harmful behaviors such as medication non-adherence. We assessed the impact of a novel patient educational tool focused on overcoming misconceptions among patients with coronary artery disease (CAD).

Methods

We developed the CAD Roadmap, an educational tool aimed at explaining the disease trajectory and overcoming common disease misconceptions (such as that statin medications are not beneficial). We designed a pilot survey to assess patients' 1) CAD-related knowledge, 2) medication-taking behavior, and 3) acceptability of the Roadmap. Survey participants were recruited online. CAD knowledge scores were compared with repeated measures t-tests.

Results

Among 114 patients with CAD (mean age 67 years, 63% male), average CAD-related knowledge was 79.0% pre-test and 89.7% after review of the CAD Roadmap (p < .001). After review of the Roadmap, 24% indicated they planned to take their medications more regularly, 93% agreed it was helpful in understanding medication benefits, and 77% felt more empowered to participate in medical decisions.

Conclusion

The CAD Roadmap was evaluated positively, improved disease-related knowledge, and has the potential to improve adherence to treatments.

Innovation

Unlike many other interventions, the CAD Roadmap is specifically designed to overcome common misconceptions to improve health behaviors.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

以患者为中心的工具对减少冠心病及其治疗误解的影响：CAD 路线图

目标健康误导很常见，可能导致不遵医嘱用药等有害行为。我们评估了一种新型患者教育工具对克服冠状动脉疾病（CAD）患者误解的影响。方法我们开发了 CAD 路线图，这是一种旨在解释疾病轨迹和克服常见疾病误解（如他汀类药物无益）的教育工具。我们设计了一项试验性调查，以评估患者的 1) CAD 相关知识、2) 服药行为和 3) 对路线图的接受程度。调查参与者通过网络招募。结果在 114 名 CAD 患者（平均年龄 67 岁，63% 为男性）中，CAD 相关知识的平均知晓率在测试前为 79.0%，在阅读 CAD 路线图后为 89.7%（p <.001）。在看过路线图后，24% 的人表示他们计划更有规律地服药，93% 的人同意路线图有助于他们了解药物的益处，77% 的人认为自己更有能力参与医疗决策。创新与许多其他干预措施不同，CAD 路线图是专门为克服常见误解以改善健康行为而设计的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊